The BioSecure Act & Unfiltered Supply Chain Realities
Source: Outsourced Pharma
This segment of the Outsourced Pharma Live event, “The Unfiltered Truth About CDMO Selection”, addresses the critical necessity of gaining supplier-level visibility for raw materials and packaging amidst geopolitical risks, while exploring the unfiltered reality that technology transfers to established US-based suppliers take significant time and capital to execute properly. Featuring panelists Jana Spes, CEO & Co-founder, JT Biopharma Partners, and Christine Sheaffer, Manufacturing & Supply Consultant, Fmr, VP of Manufacturing & Supply, Spark Therapeutics.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.
Subscribe to Outsourced Pharma
X
Subscribe to Outsourced Pharma